This course will review the new data and standard of care for each disease state of prostate cancer.  It will start with very low risk disease and go through intermediate risk, high risk, locally advanced, node positive, oligometastatic, and post-operative and will describe what the presenter wou

This course will provide radiation oncologists with the up-to-date management of patients with lymphoma, including clinical decision making on who benefits from radiotherapy, the optimal dose/fractionation, and technical aspects of treatment including involved site/node radiotherapy and advanced

This educational activity will focus on the radiation therapy treatment scenarios commonly faced in practice; i.e., breast radiation for early stage disease undergoing breast conservation and regional nodal irradiation for node positive breast cancer.  Breast radiation following lumpectomy for du

Multidisciplinary management of head and neck cancers is essential to both understanding current treatment paradigms and tailoring treatment to the individual patient.  Part of optimizing care is to understand how to intensify treatment in unfavorable cases while deescalating therapy in low risk

This course reviews the current state of treatment paradigms for the most common pediatric solid tumors requiring radiotherapy. The pitfalls and how to avoid them during treatment planning and best practices will be discussed.

This panel session brings together four experts who can present recent advances in gynecological oncology research and how it can guide our current practice.

In this practical, case based educational session we will review fundamental elements of spine SBRT by reviewing 3 specific case scenarios: 

This workshop was developed in collaboration between ASTRO and Society for Immunotherapy of Cancer (SITC). The workshop provides examples of different settings and study design to test currently available commercial immunotherapies combined with radiation therapy.

This panel focused on the guideline recommendations and videntiary base for radiation treatment of basal and squamous cell cancers of the skin.

In this session, presenters will discuss the controversies involved in radiotherapy decision-making in the era of neoadjuvant systemic therapy. Data from randomized trials will be described where available, along with the relevant strengths and limitations.